Owlstone secures $6.5M for breath-based diagnostics for infectious disease

Owlstone secures $6.5M for breath-based diagnostics for infectious disease

Source: 
Pharmaphorum
snippet: 

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.